Human papillomavirus-related malignant neoplasm
Clinical trials for Human papillomavirus-related malignant neoplasm explained in plain language.
Never miss a new study
Get alerted when new Human papillomavirus-related malignant neoplasm trials appear
Sign up with your email to follow new studies for Human papillomavirus-related malignant neoplasm, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could fewer HPV vaccine doses offer lasting protection?
Prevention By invitation onlyThis study follows women who previously received either one or two doses of the Gardasil9 HPV vaccine to see how long protection against HPV infection lasts. Researchers will check for persistent infections with HPV types linked to cancer. The goal is to understand if fewer doses…
Matched conditions: HUMAN PAPILLOMAVIRUS-RELATED MALIGNANT NEOPLASM
Phase 4 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated Sep 03, 2026 00:00 UTC
-
Can reminders and education prevent cervical cancer? a new trial aims to find out.
Prevention OngoingThis trial tests whether a program that combines educational materials with electronic health record reminders can increase HPV vaccination rates among children and young adults aged 11–26 in four Appalachian states. The goal is to improve vaccine uptake and ultimately prevent ce…
Matched conditions: HUMAN PAPILLOMAVIRUS-RELATED MALIGNANT NEOPLASM
Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Prevention
Last updated Jun 27, 2026 14:00 UTC
-
Could one HPV shot be enough? 20-Year study seeks answers
Knowledge-focused OngoingThis study is checking how long the HPV vaccine protects women who received one, two, or three doses. Researchers are following about 946 women from an earlier trial in Costa Rica for up to 20 years after their shots. By testing blood samples, they hope to learn if one dose might…
Matched conditions: HUMAN PAPILLOMAVIRUS-RELATED MALIGNANT NEOPLASM
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC